Sanofi, Merck To End European Joint Vaccine Venture

Law360, New York (March 8, 2016, 2:35 PM EST) -- Merck & Co. and Sanofi SA are disbanding their joint vaccine venture in Europe, the companies announced on Tuesday, saying that they plan to go their separate ways by the end of the year after more than 20 years of working together.

Upon ending the partnership, known as Sanofi Pasteur MSD and owned equally by both companies, they plan to integrate their respective European vaccine businesses into their other operations and independently pursue their own strategies on the continent. The breakup is expected to be completed by the end of 2016, subject to local labor laws and other regulations, the companies said....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!